Oversold Conditions For Inotek Pharmaceuticals (ITEK)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Tuesday, shares of Inotek Pharmaceuticals Corp ( ITEK) entered into oversold territory, hitting an RSI reading of 29.9, after changing hands as low as $6.30 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 67.5. A bullish investor could look at ITEK's 29.9 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of ITEK shares:

Find out what 9 other oversold stocks you need to know about »

Inotek Pharmaceuticals Corp 1 Year Performance Chart

Looking at the chart above, ITEK's low point in its 52 week range is $5.81 per share, with $12.41 as the 52 week high point — that compares with a last trade of $6.35.

If you liked this article you might like

These 5 Stocks Under $10 Could Explode Higher Soon

Inotek Pharma Shares Plummet Following Negative Glaucoma Trial Results

Inotek Pharma Glaucoma Drug Suffers Study Setback at Start of New Year

17 Thoughts on Biotech Stocks to Kick Off 2017

7 Stocks Under $10 Making Big Moves Higher